Video Experimental Relacionado

Updated: May 5, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Efecto sinérgico de los grupos de guanidinium y aminas terciarias en el aumento de la entrega de genes

Yinghao Li^1,2, Jiahao Liu¹, Liang Yao²

¹Institute of Precision Medicine (AUST-IPM), Anhui University of Science and Technology, Huainan, China.

|August 29, 2025

Resumen

Un nuevo sistema de administración de poli-β-amino ésteres mejora las terapias de ácido nucleico (ADN / ARNm) mediante la combinación de grupos de guanidinium y aminas terciarias. Este avance mejora la absorción celular y la eficiencia de la transfección, superando los estándares actuales con una toxicidad reducida.

Área de la Ciencia:

Biotecnología
Ciencias de los materiales
Entrega de drogas

Sus antecedentes:

Las terapias con ácido nucleico se enfrentan a desafíos de entrega, lo que dificulta las aplicaciones clínicas.
El desarrollo de vectores de entrega seguros y eficientes es crucial para el avance de la terapia génica y las vacunas de ARNm.

Objetivo del estudio:

Diseñar y desarrollar un sistema versátil de administración basado en poli-β-amino ésteres (PAE) para la administración mejorada de ácido nucleico (ADN/ARNm).
Investigar los efectos sinérgicos del guanidinium y los grupos funcionales de aminas terciarias en el rendimiento del vector de entrega.

Principales métodos:

Análisis sistemático de las interacciones sinérgicas utilizando 2D-NMR, AFM, TEM y caracterización fotofísica.
Evaluación del autoensamblaje y de la formación de estructuras poliplexas al mezclar polímeros.
Evaluación de la absorción celular y la eficiencia de la transfección in vitro y in vivo.

Principales resultados:

El nuevo sistema de EAP demostró una mayor liberación de ácido nucleico debido a las interacciones sinérgicas de los grupos funcionales.
El autoensamblaje de polímeros condujo a interacciones moleculares alteradas y estructuras de políplex, mejorando la absorción celular.
Las formulaciones optimizadas de EAP mostraron una eficiencia de transfección superior in vitro para el ADN y el ARNm en comparación con los reactivos comerciales.
Los estudios in vivo confirmaron un alto rendimiento de transfección, una citotoxicidad reducida y capacidades sintonizables de orientación de órganos.

Conclusiones:

El sistema de administración basado en EAP desarrollado ofrece una solución prometedora para la administración segura y eficiente de ácido nucleico.
Los efectos sinérgicos del guanidinium y los grupos de aminas terciarias son clave para mejorar el rendimiento del vector.
Este sistema versátil tiene potencial para avanzar en las terapias de ácido nucleico y las aplicaciones de administración de genes.

Palabras clave:

el guanidinio Entrega de ácido nucleico poli (β-amino éster) y sus derivados Vector polimérico Efecto sinérgico

Más Videos Relacionados

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

Videos de Conceptos Relacionados

GTPases and their Regulation

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

Activation and Inactivation of G Proteins

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...